These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22878609)

  • 1. Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.
    Kahlert C; Gaitzsch E; Steinert G; Mogler C; Herpel E; Hoffmeister M; Jansen L; Benner A; Brenner H; Chang-Claude J; Rahbari N; Schmidt T; Klupp F; Grabe N; Lahrmann B; Koch M; Halama N; Büchler M; Weitz J
    Ann Surg Oncol; 2012 Dec; 19(13):4193-201. PubMed ID: 22878609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.
    Kahlert C; Bergmann F; Beck J; Welsch T; Mogler C; Herpel E; Dutta S; Niemietz T; Koch M; Weitz J
    BMC Cancer; 2011 Jun; 11():275. PubMed ID: 21708005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative distribution of membranous and cytoplasmic met is a prognostic indicator in stage I and II colon cancer.
    Ginty F; Adak S; Can A; Gerdes M; Larsen M; Cline H; Filkins R; Pang Z; Li Q; Montalto MC
    Clin Cancer Res; 2008 Jun; 14(12):3814-22. PubMed ID: 18559601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
    Tweedle EM; Khattak I; Ang CW; Nedjadi T; Jenkins R; Park BK; Kalirai H; Dodson A; Azadeh B; Terlizzo M; Grabsch H; Mueller W; Myint S; Clark P; Wong H; Greenhalf W; Neoptolemos JP; Rooney PS; Costello E
    Gut; 2010 Nov; 59(11):1501-10. PubMed ID: 20947885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
    Wang L; Lin D; Fu Y; Lai M
    Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
    J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
    Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
    Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
    Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
    Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.
    Cho YB; Yang SS; Lee WY; Song SY; Kim SH; Shin HJ; Yun SH; Chun HK
    Int J Surg Pathol; 2010 Jun; 18(3):201-6. PubMed ID: 19372085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer.
    Aguiar S; Lopes A; Soares FA; Rossi BM; Ferreira FO; Nakagawa WT; Carvalho AL; Filho WJ
    Eur J Surg Oncol; 2005 Oct; 31(8):863-8. PubMed ID: 15923105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.